You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
McKesson
Merck
McKinsey
AstraZeneca

Last Updated: April 1, 2020

DrugPatentWatch Database Preview

HETRAZAN Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Hetrazan, and what generic alternatives are available?

Hetrazan is a drug marketed by Lederle and is included in one NDA.

The generic ingredient in HETRAZAN is diethylcarbamazine citrate. There are five drug master file entries for this compound. Additional details are available on the diethylcarbamazine citrate profile page.

Summary for HETRAZAN
Drug patent expirations by year for HETRAZAN
Synonyms for HETRAZAN
1-(N,N-Diethylcarbamoyl)-4-methylpiperazine
1-Diethylcarbamoyl-4-Methylpiperazine
1-Diethylcarbamoyl-4-methylpiperzine
1-Diethylcarbamyl-4-methylpiperazine
1-Methyl-4-diethylcarbamoylpiperazine
1-Piperazinecarboxamide, N,N-diethyl-4-methyl-
4-23-00-00225 (Beilstein Handbook Reference)
84L
90-89-1
AB00053457
AB00053457_12
AI3-19612
AK158485
AKOS003268016
Banocide (Salt/Mix)
Bitirazine
BPBio1_000208
BRD-K45542189-048-05-6
BRD-K45542189-048-15-5
BRN 0143029
BSPBio_000188
BSPBio_002179
C07968
Camin (TN)
Caracide
Carbamazine
Carbilazine
Caricide
Caritrol (Salt/Mix)
CHEBI:4527
CHEMBL684
Cypip
D07825
DB-080764
DB00711
Diaethylcarbamazinum
Diethyl carbamazine
diethyl carbamazine citrate
diethylcarbamazine
Diethylcarbamazine (INN)
Diethylcarbamazine [INN:BAN]
Diethylcarbamazinum
Diethylcarbamazinum [INN-Latin]
Dietilcarbamazina
Dietilcarbamazina [INN-Spanish]
Ditrazine Base
DivK1c_000548
DS-9360
DTXSID1022928
EC 202-023-3
EINECS 202-023-3
Ethodryl
FT-0624832
HMS3604F12
IDI1_000548
KBio1_000548
KBio2_001418
KBio2_003986
KBio2_006554
KBio3_001399
KBioGR_001081
KBioSS_001418
KS-00000JRC
LS-110688
Luxuran
MCULE-7296820622
MMV002816
N,N-Diethyl-4-methyl-1-piperazinecarboxamide
N,N-diethyl-4-methyl-piperazine-1-carboxamide
N,N-diethyl-4-methylpiperazine-1-carboxamide
N,N-diethyl(4-methylpiperazinyl)carboxamide
N,N-Diethylcarbamazine
NCGC00178778-01
NCGC00178778-02
NE55264
Nemacide (Salt/Mix)
NINDS_000548
Notezine
NSC1364
Oxacyclohexadeca-3,5,11,13-tetraen-2-one, 8-hydroxy-16-[(1S,2R,3S)-2-hydroxy-1-methyl-3-[(2R,4R,5S,6R)-tetrahydro-2,4-dihydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]butyl]-3,15-dimethoxy-5,7,9,11-tetramethyl-, (3Z,5E,7R,
Prestwick0_000284
Prestwick1_000284
Prestwick2_000284
Prestwick3_000284
Q409267
R.P. 3799
RCKMWOKWVGPNJF-UHFFFAOYSA-N
RP 3799
SBB008185
SBI-0051345.P003
SCHEMBL67289
Spatonin
SPBio_001203
SPBio_002407
Spectrum_000938
Spectrum2_001022
Spectrum3_000390
Spectrum4_000511
Spectrum5_000877
ST094965
ST24048179
UNII-V867Q8X3ZD
V867Q8X3ZD
ZINC1288

US Patents and Regulatory Information for HETRAZAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle HETRAZAN diethylcarbamazine citrate TABLET;ORAL 006459-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
McKesson
Merck
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.